PROTEOMICS INTERNATIONAL LABORATORIES LIMITED

Other languages Proteomics International Laboratories Limited

Equities

PIQ

AU000000PIQ0

Market Closed - Australian S.E. Other stock markets 01:22:03 2024-04-26 am EDT			5-day change	1st Jan Change
1.095 ^AUD	+0.46%		-2.23%	+22.35%

Mar. 25	Proteomics International Signs Agreement with University of Oxford for Endometriosis Study	MT
Mar. 19	Proteomics Says PromarkerD's US Launch Delayed	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Proteomics International Signs Agreement with University of Oxford for Endometriosis Study	Mar. 24
Proteomics Says PromarkerD's US Launch Delayed	Mar. 19
Proteomics International Laboratories Secures ISO 13485 Certification Renewal	Mar. 05
Proteomics International Laboratories Narrows Fiscal H1 Loss	Feb. 23
Proteomics International Laboratories Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22
Proteomics International's Blood Test for Uterine Disease Undergoes Biomarker Validation	Feb. 01
Proteomics International's Blood Test for Throat Cancer Undergoes Biomarker Validation	Feb. 01
Proteomics International Laboratories Raises AU$6.5 Million for Test Commercialization, Further Development; Shares Down 10%	Jan. 22
Proteomics Signs Deal to Sell PromarkerD in Chile; Shares Jump 5%	Dec. 19
Proteomics International Laboratories Receives More than AU$1.8 Million R&D Tax Rebate	Nov. 08
Proteomics International Subsidiary Secures New Patent in Japan; Shares Fall 4%	23-09-03
Proteomics International Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-21
Proteomics International Laboratories Signs Deal to Commercialize Diagnostic Test in the US; Shares Rally 11%	23-05-09
Proteomics International Laboratories Renews ISO 13485 Certification, ISO 17025 Accreditation	23-04-16
Proteomics International Laboratories to Resubmit Medicare Application for Diagnostic Test in Australia	23-03-15
Proteomics International Laboratories Limited Announces to Resubmit Application for PromarkerD Listing on Australian Medicare Benefits Schedule	23-03-15
Proteomics International Laboratories Limited Provides Update on Exclusive Licence Agreement with Sonic Healthcare USA, Inc	23-02-28
Proteomics International Laboratories Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26
Proteomics International Laboratories Extends Predictive Test Distribution Agreement in Britain	23-02-15
Proteomics International Laboratories Ltd Extends its Distribution Agreement with Apacor Limited to Bring its PromarkerD Predictive Test for Diabetic Kidney Disease to Patients in England, Scotland and Wales	23-02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Proteomics International Laboratories Limited

Equities

PIQ

AU000000PIQ0

Other languages

Filters